Dietary tricin suppresses inflammation-related colon carcinogenesis in male Crj: CD-1 mice

Cancer Prevention Research

Volumn 2, Issue 12, 2009, Pages 1031-1038

  Oyama, Takeru ^a   Yasui, Yumiko ^a   Sugie, Shigeyuki ^a   Koketsu, Mamoru ^b   Watanabe, Kunitomo ^b   Tanaka, Takuji ^a,c  

^a KANAZAWA MEDICAL UNIVERSITY   (Japan)

^b GIFU UNIVERSITY   (Japan)

^c Tohkai Cytopathology Institute: Cancer Research and Prevention   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AZOXYMETHANE; DEXTRAN SULFATE; DRINKING WATER; FLAVONE 4',5,7 TRIHYDROXY 3',5' DIMETHOXYFLAVONE; FLAVONE DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CARCINOGEN; FLAVONOID; MESSENGER RNA; PLANT EXTRACT; TRICIN;

ANAPHASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CANCER INHIBITION; CANCER PREVENTION; CELL PROLIFERATION; CHEMOPROPHYLAXIS; COLON ADENOCARCINOMA; COLON ADENOMA; COLON CARCINOGENESIS; CONTROLLED STUDY; CRYPT CELL; CYTOKINE PRODUCTION; DIETARY INTAKE; DISEASE ASSOCIATION; DRUG EFFECT; GASTROINTESTINAL DYSPLASIA; INTESTINE MUCOSA; INTESTINE ULCER; MALE; MITOSIS INDEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; ADENOCARCINOMA; ADENOMA; ANIMAL; CHEMICALLY INDUCED DISORDER; COLON TUMOR; DIET; GENETICS; IMMUNOLOGY; INFLAMMATION; INSTITUTE FOR CANCER RESEARCH MOUSE; METABOLISM; PHYTOTHERAPY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ADENOCARCINOMA; ADENOMA; ANIMALS; AZOXYMETHANE; BLOTTING, WESTERN; CARCINOGENS; COLONIC NEOPLASMS; DIET; FLAVONOIDS; INFLAMMATION; MALE; MICE; MICE, INBRED ICR; PHYTOTHERAPY; PLANT EXTRACTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 76549119214     PISSN: 19406207     EISSN: None     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-09-0061     Document Type: Article

References (43)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin 2008;58:71-96.
2. Karim-Kos HE, de Vries E, Soerjomataram I, Lemmens V, Siesling S, Coebergh JW. Recent trends of cancer in Europe: a combined approach of incidence, survival andmortality for 17 cancer sites since the 1990s. Eur J Cancer 2008;44:1345-89.
3. Tanaka T. Colorectal carcinogenesis: review of human and experimental animal studies. J Carcinog 2009;8:5.
4. Rosenberg DW, Giardina C, Tanaka T. Mouse models for the study of colon carcinogenesis. Carcinogenesis 2009;30:183-96.
5. Tanaka T. Effect of diet on human carcinogenesis. Crit Rev Oncol Hematol 1997;25:73-95.
6. Tanaka T, Miyamoto S, Suzuki R, Yasui Y. Chemoprevention of colon carcinogenesis by dietary nonnutritive compounds. Curr Top Neutraceut Res 2006;4:127-52.
7. Tanaka T, Oyama T, Yasui Y. Deietary supplements and colorectal cancer. Curr Topics Neutarceut Res 2008;6:165-88.
8. Murthy NS, Mukherjee S, Ray G, Ray A. Dietary factors and cancer chemoprevention: an overview of obesity-related malignancies. J Postgrad Med 2009;55:45-54.
9. Pan MH, Ho CT. Chemopreventive effects of natural dietary compounds on cancer development. Chem Soc Rev 2008;37:2558-74.
10. Wang HK, Xia Y, Yang ZY,Natschke SL, Lee KH. Recent advances in the discovery and development of flavonoids and their analogues as antitumor and anti-HIV agents. Adv Exp Med Biol 1998;439:191-225.
11. Park HS, Lim JH, Kim HJ, Choi HJ, Lee IS. Antioxidant flavone glycosides from the leaves of Sasa borealis. Arch Pharm Res 2007;30:161-6.
12. Fiorentino A, D'Abrosca B, Pacifico S, et al. Potential allelopatic effects of stilbenoids and flavonoids from leaves of Carex distachya Desf. Biochem Syst Ecol 2008;36:691-8.
13. Duarte-Almeida JM, Negri G, Salatino A, de Carvalho JE, Lajolo FM. Antiproliferative and antioxidant activities of a tricin acylated glycoside from sugarcane (Saccharum officinarum) juice. Phytochemistry 2007;68:1165-71.
14. Renuka Devi R, Arumughan C. Antiradical efficacy of phytochemical extracts from defatted rice bran. Food Chem Toxicol 2007;45:2014-21.
15. Sakai A, Watanabe K, Koketsu M, et al. Antihuman cytomegalovirus activity of constituents from Sasa albo-marginata (Kumazasa in Japan). Antivir Chem Chemother 2008;19:125-32.
16. Kuwabara H, Mouri K, Otsuka H, Kasai R, Yamasaki K. Tricin froma malagasy connaraceous plant with potent antihistaminic activity. JNat Prod 2003;66:1273-5.
17. Aggarwal BB, Shishodia S. Molecular targets of dietary agents for prevention and therapy of cancer. Biochem Pharmacol 2006;71:1397-421.
18. Janakiram NB, Rao CV. Molecular markers and targets for colorectal cancer prevention. Acta Pharmacol Sin 2008;29:1-20.
19. Surh YJ. Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer 2003;3:768-80.
20. Yasui Y, Kim M, Oyama T, Tanaka T. Colorectal carcinogenesis and suppression of tumor development by inhibition of enzymes and molecular targets. Curr Enzyme Inhibition 2009;5:1-26.
21. Cai H, Hudson EA, Mann P, et al. Growth-inhibitory and cell cycle-arresting properties of the rice bran constituent tricin in human-derived breast cancer cells in vitro and in nude mice in vivo. Br J Cancer 2004;91:1364-71.
22. Hudson EA, Dinh PA, Kokubun T, Simmonds MS, Gescher A. Characterization of potentially chemopreventive phenols in extracts of brown rice that inhibit the growth of human breast and colon cancer cells. Cancer Epidemiol Biomarkers Prev 2000;9: 1163-70.
23. Cai H, Al-Fayez M, Tunstall RG, et al. The rice bran constituent tricin potently inhibits cyclooxygenase enzymes and interferes with intestinal carcinogenesis in ApcMin mice. Mol Cancer Ther 2005;4:1287-92.
24. Al-Fayez M, Cai H, Tunstall R, Steward WP, Gescher AJ. Differential modulation of cyclooxygenase-mediated prostaglandin production by the putative cancer chemopreventive flavonoids tricin, apigenin and quercetin. Cancer Chemother Pharmacol 2006;58:816-25.
25. Cai H, Boocock DJ, Steward WP, Gescher AJ. Tissue distribution in mice and metabolism in murine and human liver of apigenin and tricin, flavones with putative cancer chemopreventive properties. Cancer Chemother Pharmacol 2007;60:257-66.
26. Cai H, Brown K, Steward WP, Gescher AJ. Determination of 3?OElig;,4?OElig;,5?OElig;,5,7-pentamethoxyflavone in the plasma and intestinal mucosa of mice by HPLC with UV detection. Biomed Chromatogr 2009;23:335-9.
27. Cai H, Steward WP, Gescher AJ. Determination of the putative cancer chemopreventive flavone tricin in plasma and tissues of mice by HPLC with UV-visible detection. Biomed Chromatogr 2005; 19:518-22.
28. Cai H, Verschoyle RD, Steward WP, Gescher AJ. Determination of the flavone tricin in human plasma by high-performance liquid chromatography. Biomed Chromatogr 2003;17:435-9.
29. Tanaka T, Yasui Y, Ishigamori-Suzuki R, Oyama T. Citrus compounds inhibit inflammation- and obesity-related colon carcinogenesis in mice. Nutr Cancer 2008;60 Suppl 1:70-80.
30. Tanaka T, Yasui Y, Tanaka M, Oyama T, Rahman KM. Melatonin suppresses AOM/DSS-induced large bowel oncogenesis in rats. Chem Biol Interact 2009;177:128-36.
31. Suzuki R, Kohno H, Sugie S, Tanaka T. Sequential observations on the occurrence of preneoplastic and neoplastic lesions in mouse colon treated with azoxymethane and dextran sodium sulfate. Cancer Sci 2004;95:721-7.
32. Suzuki R, Kohno H, Sugie S, Tanaka T. Dose-dependent promoting effect of dextran sodium sulfate on mouse colon carcinogenesis initiated with azoxymethane. Histol Histopathol 2005;20:483-92.
33. Tanaka T, Kohno H, Suzuki R, et al. Dextran sodium sulfate strongly promotes colorectal carcinogenesis in Apc(Min/+) mice: inflammatory stimuli by dextran sodium sulfate results in development of multiple colonic neoplasms. Int J Cancer 2006; 118:25-34.
34. Tanaka T, Kohno H, Suzuki R, Yamada Y, Sugie S, Mori H. A novel inflammation-related mouse colon carcinogenesis model induced by azoxymethane and dextran sodium sulfate. Cancer Sci 2003;94: 965-73.
35. Reddy BS. Studies with the azoxymethane-rat preclinical model for assessing colon tumor development and chemoprevention. Environ Mol Mutagen 2004;44:26-35.
36. Reddy BS, Rao CV. Chemoprophylaxis of colon cancer. Curr Gastroenterol Rep 2005;7:389-95.
37. Rao CV. Regulation of COX and LOX by curcumin. Adv Exp Med Biol 2007;595:213-26.
38. Rao CV. Nitric oxide signaling in colon cancer chemoprevention. Mutat Res 2004;555:107-19.
39. Sethi G, Sung B, Aggarwal BB. TNF: a master switch for inflammation to cancer. Front Biosci 2008;13:5094-107.
40. Aggarwal BB, Shishodia S, Sandur SK, Pandey MK, Sethi G. Inflammation and cancer: how hot is the link? Biochem Pharmacol 2006;72:1605-21.
41. Rudolph KL, Millard M, Bosenberg MW, DePinho RA. Telomere dysfunction and evolution of intestinal carcinoma in mice and humans. Nat Genet 2001;28:155-9.
42. Yamada Y, Hata K, Hirose Y, et al. Microadenomatous lesions involving loss of Apc heterozygosity in the colon of adult Apc(Min/+) mice. Cancer Res 2002;62:6367-70.
43. Verschoyle RD, Greaves P, Cai H, et al. Preliminary safety evaluation of the putative cancer chemopreventive agent tricin, a naturally occurring flavone. Cancer Chemother Pharmacol 2006;57:1-6.